296) triclabendazole significantly reduced the tumor volume by promoting the cleavage of |
297) odel, CD40L-MTV-NPs significantly reduced tumor volume in correlation with significa |
298) Therapeutic efficacy was assessed by tumor volume measurements (CT), time to pr |
299) mother-daughter pair, a somatic cause of tumor MMR deficiency was supported by the |
300) fidently assigned a noninherited cause of tumor MMR deficiency. |
301) isorders related to the vertebrae, spinal tumor ablation, vertebral augmentation, an |
302) ave been widely studied, including spinal tumor ablation, vertebral augmentation, an |
303) agonist 2'3'-cGAMP, TLR9 ligand CpG, and tumor antigen peptides that are loaded int |
304) ugates (ADCs) combine the highly targeted tumor antigen recognition of antibodies wi |
305) CD4+T cells from non-tumor bearing mice were isolated from sple |
306) rom draining lymph nodes and spleens from tumor bearing C57Bl/6 mice, 28 days post-i |
307) s the sensitivity of radiomic features to tumor boundaries. |
308) ified sensitivity of radiomic features to tumor boundaries. |
309) overcame insufficient immunity at distant tumor caused by PTT alone and relieved imm |
310) ercoming insufficient immunity at distant tumor caused by PTT alone. |
311) sessed and optimized in order to maximize tumor-absorbed dose while keeping normal o |
312) Such imaging may be used to estimate tumor-absorbed dose. |
313) ws the research results on organoids from tumor drug screening. |
314) ir applications in cancer therapy include tumor-targeting drug delivery and controll |
315) and anti-PD-1 cotreatment may enhance antitumor effects consistent with an increase |
316) ide the first line of defense against the tumor-promoting effects of oxidative stres |
317) D20 CAR T cells demonstrate improved anti-tumor efficacy in response to dual antigen |
318) In this study, we evaluated the anti-tumor efficacy of DARA conjugated to the m |
319) free method to examine specimens of both tumor entities intraoperatively, as well a |
320) rest classification distinguished the two tumor entities with a balanced accuracy of |
321) Both, glioblastoma and tumor-associated epilepsy are closely link |
322) ressing glutamate receptors in glioma and tumor-related epilepsy will be highlighted |
323) A merit in the early stages of tumor formation, autophagy appears to be s |
324) In the early stages of tumor formation, autophagy appears to be s |
325) However, the inter-patient and intra-tumor heterogeneity has not been addressed |
326) Genetic investigation of tumor heterogeneity and clonal evolution i |
327) rences across patients, and the impact of tumor hypoxia on response to RPT. |
328) mic therapy (PDT) of cancer is limited by tumor hypoxia. |
|